X-linked dominant Charcot–Marie–Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations
Jan Senderek(Friedrich Baur Stiftung), J. M. Schröder(Maastricht University), Malek Bajbouj(Klinik und Poliklinik für Psychiatrie und Psychotherapie), Stefan Quasthoff(Technical University of Munich), Carsten Bergmann(University Medical Center Freiburg), Dieter Karch(SLK-Kliniken Heilbronn), Babak Boroojerdi(UCB Pharma (Germany)), Benita Hermanns(Universitätsklinikum Aachen), Vincent T. Ramaekers(Universitätsklinikum Aachen), Marcel Hungs(RWTH Aachen University)
Cited by 86
Related Papers
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
|American Journal of Psychiatry|2019|888
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
|The American Journal of Human Genetics|2007|449
TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum
|Nature Genetics|2011|381
Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy
|Nature Genetics|2010|325